Duenweg, S.R.; Bobholz, S.A.; Barrett, M.J.; Lowman, A.K.; Winiarz, A.; Nath, B.; Stebbins, M.; Bukowy, J.; Iczkowski, K.A.; Jacobsohn, K.M.;
et al. T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical Recurrence. Cancers 2023, 15, 4437.
https://doi.org/10.3390/cancers15184437
AMA Style
Duenweg SR, Bobholz SA, Barrett MJ, Lowman AK, Winiarz A, Nath B, Stebbins M, Bukowy J, Iczkowski KA, Jacobsohn KM,
et al. T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical Recurrence. Cancers. 2023; 15(18):4437.
https://doi.org/10.3390/cancers15184437
Chicago/Turabian Style
Duenweg, Savannah R., Samuel A. Bobholz, Michael J. Barrett, Allison K. Lowman, Aleksandra Winiarz, Biprojit Nath, Margaret Stebbins, John Bukowy, Kenneth A. Iczkowski, Kenneth M. Jacobsohn,
and et al. 2023. "T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical Recurrence" Cancers 15, no. 18: 4437.
https://doi.org/10.3390/cancers15184437
APA Style
Duenweg, S. R., Bobholz, S. A., Barrett, M. J., Lowman, A. K., Winiarz, A., Nath, B., Stebbins, M., Bukowy, J., Iczkowski, K. A., Jacobsohn, K. M., Vincent-Sheldon, S., & LaViolette, P. S.
(2023). T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical Recurrence. Cancers, 15(18), 4437.
https://doi.org/10.3390/cancers15184437
